EUITAS
LIVE

Serial Number

86848984

Owner

B D Forrest & Company, Inc.

First Use Date

Apr 21, 2015

Filing Date

Dec 14, 2015

Add to watchlist:

No watchlists yet
View on USPTO

EUITAS Trademark

Serial Number: 86848984 • Registration: 5030561

EUITAS is a trademark filed by B D Forrest & Company, Inc. on December 14, 2015. The trademark is classified under Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

B D Forrest & Company, Inc. (5 trademarks)

135 Piermont Avenue
South Nyack, NY 109604513

Entity Type: 03

HUDSON INNOVATIONS, LLC (3 trademarks)

PO BOX 444
NYACK, NY 10960

Entity Type: 16

Equitas Bio/Pharma Solutions, LLC (2 trademarks)

4111 W. Inman Avenue
Tampa, FL 33609

Entity Type: 16

Trademark Details

Filing Date

December 14, 2015

Registration Date

August 30, 2016

First Use Anywhere

April 21, 2015

First Use in Commerce

April 21, 2015

Published for Opposition

June 14, 2016

Goods & Services

Pharmaceutical and biopharmaceutical business plan development; business consultation services in the field of pharmaceutical and biopharmaceutical regulatory strategy; business consultation in the field of pharmaceutical and biopharmaceutical foreign market entry; business management services in the field of pharmaceutical and biopharmaceutical products and medical devices; business development and commercial administration of the licensing of pharmaceutical and biopharmaceutical products and medical devices; Providing advertising, marketing and promotional services for pharmaceutical and biopharmaceutical products and medical devices; marketing plan development for pharmaceutical and biopharmaceutical products and medical devices; market research and business analyses and advice for pharmaceutical and biopharmaceutical products and medical devices

Consulting in the field of pharmaceutical and biopharmaceutical regulations with regard to regulatory strategy

Consulting services, namely, pharmaceutical and biopharmaceutical product development; pharmaceutical and biopharmaceutical clinical development and product testing; research and development of pharmaceutical and biopharmaceutical products and medical device

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Dec 15, 2025 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Dec 15, 2025 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Dec 15, 2025 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 11, 2025 APRE
TEAS SECTION 8 & 9 RECEIVED
Aug 30, 2025 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Aug 30, 2025 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Aug 25, 2022 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Aug 25, 2022 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 2, 2022 APRE
TEAS SECTION 8 RECEIVED
Mar 9, 2022 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 30, 2021 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 24, 2020 ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 15, 2018 ASGN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 28, 2016 TCCA
REGISTERED-PRINCIPAL REGISTER
Aug 30, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 14, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jun 14, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 25, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 9, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 19, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 18, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 18, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 30, 2016 GNRN
NON-FINAL ACTION E-MAILED
Mar 30, 2016 GNRT
NON-FINAL ACTION WRITTEN
Mar 30, 2016 CNRT
ASSIGNED TO EXAMINER
Mar 29, 2016 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 22, 2015 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 19, 2015 NWOS
NEW APPLICATION ENTERED
Dec 17, 2015 NWAP